dronabinol has been researched along with Antibody Deficiency Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bradley, SG | 1 |
Friedman, H; Lancz, G; Specter, S; Westrich, G | 1 |
Borysenko, M; Kumar, MS; Millard, WJ; Patel, V | 1 |
1 review(s) available for dronabinol and Antibody Deficiency Syndrome
Article | Year |
---|---|
Drugs of abuse and infections.
Topics: Animals; Antibody Formation; Cells, Cultured; Cytotoxicity, Immunologic; Disease Susceptibility; Dronabinol; Drug Interactions; Drug Tolerance; Endotoxins; Genetic Predisposition to Disease; Humans; Illicit Drugs; Immunity, Innate; Immunologic Deficiency Syndromes; Infections; Lipopolysaccharides; Mice; Mice, Inbred C3H; Species Specificity | 1991 |
2 other study(ies) available for dronabinol and Antibody Deficiency Syndrome
Article | Year |
---|---|
Combined immunosuppressive activities of delta-9-tetrahydrocannabinol and murine retrovirus.
Topics: Animals; Depression, Chemical; Disease Susceptibility; Dronabinol; Female; Friend murine leukemia virus; Herpes Simplex; Immune Tolerance; Immunologic Deficiency Syndromes; Killer Cells, Natural; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mitogens; Opportunistic Infections; Polycythemia; Tumor Virus Infections | 1991 |
Effects of acute and subchronic delta 9-tetrahydrocannabinol administration on the plasma catecholamine, beta-endorphin, and corticosterone levels and splenic natural killer cell activity in rats.
Topics: Animals; beta-Endorphin; Catecholamines; Corticosterone; Dronabinol; Endorphins; Immunologic Deficiency Syndromes; Injections, Subcutaneous; Killer Cells, Natural; Male; Naloxone; Rats; Rats, Inbred Strains; Spleen | 1985 |